FDA Approves Second Brain Amyloid Imaging Tracer
Medscape NeurologyHeadlines
The FDA announced approval today for flutemetamol (Vizamyl, GE Healthcare), a second amyloid PET tracer for evaluation of AD and dementia.
FDA Approvals
Original Article: http://www.medscape.com/viewarticle/813222?src=rss
No comments:
Post a Comment